By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
DrugPatentWatch Database Preview
Drugs in Development Information for Givinostat
Email this page to a colleague
What is the drug development status for Givinostat?
Givinostat is an investigational drug.
There have been 9 clinical trials for Givinostat.
The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2016.
The most common disease conditions in clinical trials are Muscular Dystrophy, Duchenne, Muscular Dystrophies, and Polycythemia. The leading clinical trial sponsors are Italfarmaco, inVentiv Health Clinical, and Parexel.
There are three hundred and seventeen US patents protecting this investigational drug and two international patents.
Summary for Givinostat
| US Patents | 317 |
| International Patents | 2,364 |
| US Patent Applications | 805 |
| WIPO Patent Applications | 661 |
| Japanese Patent Applications | 208 |
| Clinical Trial Progress | Phase 2 (2016-10-01) |
| Vendors | 20 |
Recent Clinical Trials for Givinostat
| Title | Sponsor | Phase |
|---|---|---|
| Placebo-Corrected Effects of Therapeutic Dose (100 mg) and Supratherapeutic Dose (300 mg) of ITF2357 (Givinostat) and Moxifloxacin on QT/QTC Interval | Italfarmaco | Phase 1 |
| Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Becker Muscular Dystrophy | Italfarmaco | Phase 2 |
| Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy | inVentiv Health Clinical | Phase 3 |
Clinical Trial Summary for Givinostat
Top disease conditions for Givinostat
Top clinical trial sponsors for Givinostat
US Patents for Givinostat
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Givinostat | Try Before You Buy | Histone deacetylase inhibitors and methods for use thereof | REACTION BIOLOGY CORP. (Malvern, PA) | Try Before You Buy |
| Givinostat | Try Before You Buy | Anti-CS1 antibodies and antibody drug conjugates | AbbVie Biotherapeutics Inc. (Redwood City, CA) | Try Before You Buy |
| Givinostat | Try Before You Buy | Histone deacetylase 6 inhibition for enhancing T-cell function during anti-tumor response and tumor-peptide vaccination | H. Lee Moffitt Cancer Center and Research Institute, Inc. (Tampa, FL) | Try Before You Buy |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Givinostat
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Givinostat | World Intellectual Property Organization (WIPO) | WO2017030892 | 2035-08-14 | Try Before You Buy |
| Givinostat | Australia | AU2015339012 | 2034-10-31 | Try Before You Buy |
| Givinostat | Brazil | BR112017008945 | 2034-10-31 | Try Before You Buy |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
